NPI: 1801807870 · LODI, OH 44254 · Critical Access Hospital · NPI assigned 08/11/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 08/11/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,872 | $229K |
| 2019 | 5,808 | $281K |
| 2020 | 3,649 | $506K |
| 2021 | 5,119 | $1.09M |
| 2022 | 5,228 | $1.74M |
| 2023 | 26,642 | $7.29M |
| 2024 | 21,878 | $6.40M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,250 | 6,628 | $3.54M |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,760 | 1,277 | $3.15M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,355 | 3,527 | $2.83M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,622 | 3,125 | $2.31M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,910 | 1,615 | $1.25M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 660 | 503 | $847K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,582 | 522 | $605K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 500 | 318 | $497K |
| 70450 | Computed tomography, head or brain; without contrast material | 394 | 301 | $394K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 434 | 381 | $346K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 732 | 582 | $304K |
| 80053 | Comprehensive metabolic panel | 4,570 | 3,682 | $203K |
| 96127 | 274 | 159 | $160K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 128 | 90 | $132K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,067 | 931 | $90K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 181 | 143 | $90K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 80 | 52 | $75K |
| 36415 | Collection of venous blood by venipuncture | 9,168 | 7,030 | $70K |
| 71046 | Radiologic examination, chest; 2 views | 856 | 702 | $69K |
| 80061 | Lipid panel | 929 | 837 | $66K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 463 | 402 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,572 | 4,451 | $51K |
| 85027 | 1,565 | 1,279 | $49K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 251 | 239 | $45K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 102 | 38 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,702 | 1,307 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,932 | 1,455 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 160 | 100 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | 504 | 448 | $19K |
| 84439 | 130 | 110 | $13K | |
| 73630 | 154 | 123 | $12K | |
| 84702 | 179 | 113 | $12K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 13 | 13 | $11K |
| 83735 | 907 | 613 | $11K | |
| 84484 | 2,015 | 1,155 | $11K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 64 | 39 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 517 | 407 | $10K |
| 81001 | 2,720 | 2,228 | $10K | |
| 82607 | 134 | 119 | $9K | |
| 83690 | 1,032 | 725 | $7K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 32 | 25 | $7K |
| 83540 | 118 | 104 | $6K | |
| 82728 | 60 | 56 | $6K | |
| 71045 | Radiologic examination, chest; single view | 1,054 | 808 | $6K |
| 82805 | 48 | 39 | $5K | |
| 83550 | 115 | 101 | $5K | |
| 85610 | 392 | 234 | $5K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,089 | 1,603 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | 986 | 680 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 278 | 212 | $2K |
| 83880 | 122 | 90 | $2K | |
| 73030 | 20 | 12 | $2K | |
| 87400 | 195 | 174 | $2K | |
| 83605 | 711 | 457 | $2K | |
| 73130 | 29 | 25 | $2K | |
| 87077 | 114 | 86 | $2K | |
| 82746 | 29 | 25 | $1K | |
| 80076 | 22 | 14 | $1K | |
| 82570 | 49 | 44 | $1K | |
| 86140 | 30 | 25 | $1K | |
| 73610 | 52 | 39 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 342 | 299 | $1K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 18 | 13 | $993.82 |
| 82043 | 31 | 27 | $887.94 | |
| 81025 | 681 | 556 | $692.41 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 16 | 15 | $641.00 |
| 87186 | 37 | 31 | $538.43 | |
| 84132 | 100 | 84 | $533.46 | |
| 85652 | 15 | 13 | $416.19 | |
| 85379 | 32 | 28 | $394.99 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 167 | 131 | $279.22 |
| 82330 | 56 | 43 | $157.26 | |
| 82947 | 56 | 46 | $125.55 | |
| 81003 | 67 | 56 | $99.00 | |
| 82962 | 42 | 26 | $57.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 546 | 460 | $44.20 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 194 | 114 | $36.43 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,007 | 745 | $28.51 |
| 87081 | 76 | 74 | $17.11 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 830 | 619 | $8.65 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,048 | 765 | $0.34 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 26 | 15 | $0.00 |
| 85018 | 49 | 40 | $0.00 | |
| 82077 | 55 | 33 | $0.00 | |
| 87040 | 119 | 76 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 29 | 15 | $0.00 |
| 96376 | 38 | 24 | $0.00 | |
| 94760 | 24 | 13 | $0.00 | |
| 83050 | 47 | 38 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 29 | 12 | $0.00 |
| 84703 | 57 | 53 | $0.00 | |
| 82375 | 46 | 37 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 113 | 110 | $0.00 |
| 84295 | 52 | 42 | $0.00 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 22 | 19 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 16 | 14 | $0.00 |